CD8A and neoplasm: In addition, Moreover, treatment with SGLT2 inhibitor promoted tumor infiltration by CD45+CD4+ and CD45+CD8+ T cells in STING normal expressed K7M2 tumors, while not in in STING silenced K7M2 tumors (Supplementary Fig. 4h).